These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 36186578)
1. Urea-based anticancer agents. Exploring 100-years of research with an eye to the future. Listro R; Rossino G; Piaggi F; Sonekan FF; Rossi D; Linciano P; Collina S Front Chem; 2022; 10():995351. PubMed ID: 36186578 [TBL] [Abstract][Full Text] [Related]
2. Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry. Ghosh AK; Brindisi M J Med Chem; 2020 Mar; 63(6):2751-2788. PubMed ID: 31789518 [TBL] [Abstract][Full Text] [Related]
3. 1,3-Diazepine: A privileged scaffold in medicinal chemistry. Malki Y; Martinez J; Masurier N Med Res Rev; 2021 Jul; 41(4):2247-2315. PubMed ID: 33645848 [TBL] [Abstract][Full Text] [Related]
4. An overview of quinoline as a privileged scaffold in cancer drug discovery. Musiol R Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679 [TBL] [Abstract][Full Text] [Related]
6. Pyrazolyl-Ureas as Interesting Scaffold in Medicinal Chemistry. Brullo C; Rapetti F; Bruno O Molecules; 2020 Jul; 25(15):. PubMed ID: 32751358 [TBL] [Abstract][Full Text] [Related]
7. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery. Das R; Mehta DK; Dhanawat M Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282 [TBL] [Abstract][Full Text] [Related]
8. The role of sulfamide derivatives in medicinal chemistry: a patent review (2006-2008). Reitz AB; Smith GR; Parker MH Expert Opin Ther Pat; 2009 Oct; 19(10):1449-53. PubMed ID: 19650745 [TBL] [Abstract][Full Text] [Related]
9. Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea-based antineoplastic kinase inhibitors. Dokla EM; Mahmoud AH; Elsayed MS; El-Khatib AH; Linscheid MW; Abouzid KA PLoS One; 2012; 7(11):e49284. PubMed ID: 23185312 [TBL] [Abstract][Full Text] [Related]
10. Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021). Dhiman A; Sharma R; Singh RK Acta Pharm Sin B; 2022 Jul; 12(7):3006-3027. PubMed ID: 35865090 [TBL] [Abstract][Full Text] [Related]
12. Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022. Kozyra P; Pitucha M Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012142 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis. Ronchetti R; Moroni G; Carotti A; Gioiello A; Camaioni E RSC Med Chem; 2021 Jul; 12(7):1046-1064. PubMed ID: 34355177 [TBL] [Abstract][Full Text] [Related]
14. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry. Barresi E; Robello M; Baglini E; Poggetti V; Viviano M; Salerno S; Da Settimo F; Taliani S Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513909 [TBL] [Abstract][Full Text] [Related]
18. An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. Cherukupalli S; Karpoormath R; Chandrasekaran B; Hampannavar GA; Thapliyal N; Palakollu VN Eur J Med Chem; 2017 Jan; 126():298-352. PubMed ID: 27894044 [TBL] [Abstract][Full Text] [Related]
19. Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules. Kourounakis AP; Xanthopoulos D; Tzara A Med Res Rev; 2020 Mar; 40(2):709-752. PubMed ID: 31512284 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Outlook of Pyrazole Analogs: A Mini Review. Ganguly S; Jacob SK Mini Rev Med Chem; 2017; 17(11):959-983. PubMed ID: 26586126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]